Item 2.02Results of Operations and Financial Condition.

On March 9, 2021, Mirum Pharmaceuticals, Inc. (the "Company") issued a press release providing a corporate update and announcing its financial results for the quarter and year ended December 31, 2020. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01Financial Statements and Exhibits.



(d) Exhibits.



                 Exhibit
                   No.     Description

                 99.1        Press Release dated March   9, 2021

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses